Evaluate TRVI stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in TRVI? | Glauxie AI

Q: What are the risks of investing in TRVI?

Trevi Therapeutics, Inc. (TRVI) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Jennifer L. Good. Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is... Employees: 34.

Q: How much debt does TRVI have?

Review TRVI total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is TRVI a good long-term investment?

Evaluate TRVI as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in TRVI?

🦉

Trevi Therapeutics, Inc. (TRVI)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOJennifer L. Good

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III...

Key Executives

Name	Title
Christopher Galletta	Controller & Chief Accounting Officer
David C. Hastings	Chief Financial Officer & Principal Financial Officer
Farrell Simon	Chief Commercial Officer
James V. Cassella	Chief Development Officer
Jennifer L. Good	Co-Founder, Chief Executive Officer, President & Director
Katherine Takaki	Senior Vice President of Global Regulatory Affairs

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

TRVI Profile Financials

Is TRVI stock safe? How much debt does TRVI have? Is TRVI a good long-term investment?